查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1977599

聚合酵素鏈鎖反應（PCR）全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Polymerase Chain Reaction Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 122 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

聚合酵素鏈鎖反應(PCR) 市場預計將從 2025 年的 73.9 億美元成長到 2034 年的 179.2 億美元，2026 年至 2034 年的複合年成長率為 10.34%。

由於分子診斷和基因研究需求的不斷成長，全球聚合酵素鏈鎖反應(PCR) 市場正經歷顯著成長。 PCR 技術能夠快速擴增 DNA，已成為疾病檢測和法醫學分析中不可或缺的工具。感染疾病和遺傳疾病的增加推動了 PCR 技術的應用，而生物技術研發和藥物開發的拓展則進一步促進了市場成長。

關鍵成長要素包括即時PCR和數位PCR技術的進步。檢查室依靠PCR技術獲得準確快速的診斷結果。精準醫療和個人化醫療領域投資的增加也推動了市場擴張。此外，自動化和試劑配方的改進也提高了檢測效率。

隨著分子診斷在全球日益普及，其未來前景依然光明。與攜帶式和照護現場設備的整合將拓寬其應用範圍。基因組學和腫瘤學研究的不斷深入將進一步刺激市場需求。在創新和醫療進步的推動下，PCR市場預計將保持穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球聚合酵素鏈鎖反應(PCR) 市場：依產品分類

  • 市場分析、洞察與預測
  • PCR設備
  • 標準PCR系統
  • RT-PCR系統
  • 數位PCR系統
  • PCR試劑
  • PCR耗材

第5章 全球聚合酵素鏈鎖反應(PCR) 市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 製藥和生物技術產業
  • 臨床診斷檢查室和醫院
  • 學術和研究機構

第6章 全球聚合酵素鏈鎖反應（PCR）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Bio-Rad Laboratories Inc
    • Stilla
    • Standard BioTools
    • Siemens Healthineers
    • BioMerieux SA
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • Qiagen NV
    • Becton Dickinson & Company（BD）
    • Abbott Laboratories
    • Agilent Technologies
    • F. Hoffmann-La Roche Ltd
    • Microsynth AG
簡介目錄
Product Code: VMR11211450

The Polymerase Chain Reaction Market size is expected to reach USD 17.92 Billion in 2034 from USD 7.39 Billion (2025) growing at a CAGR of 10.34% during 2026-2034.

The Global Polymerase Chain Reaction market has witnessed substantial growth due to rising demand for molecular diagnostics and genetic research. PCR technology enables rapid amplification of DNA, making it essential in disease detection and forensic analysis. Increasing prevalence of infectious diseases and genetic disorders has boosted adoption. Expanding biotechnology research and pharmaceutical development further strengthen market growth.

Key growth drivers include advancements in real-time and digital PCR technologies. Laboratories rely on PCR for accurate and fast diagnostic results. Growing investment in precision medicine and personalized healthcare also supports expansion. Additionally, automation and improved reagent formulations enhance testing efficiency.

Future prospects remain promising as molecular diagnostics become more accessible worldwide. Integration with portable and point-of-care devices will broaden applications. Expanding research in genomics and oncology will further stimulate demand. The PCR market is expected to sustain steady growth driven by innovation and healthcare advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • PCR Instruments
  • Standard PCR Systems
  • RT PCR Systems
  • Digital PCR Systems
  • PCR Reagents
  • PCR Consumables

By End User

  • Pharmaceutical & Biotechnology Industries
  • Clinical Diagnostics Labs & Hospitals
  • Academic & Research Organizations

COMPANIES PROFILED

  • BioRad Laboratories Inc, Stilla, Standard BioTools, Siemens Healthineers, BioMerieux SA, Danaher Corporation, Thermo Fisher Scientific Inc, Qiagen NV, Becton Dickinson Company BD, Abbott Laboratories, Agilent Technologies, F HoffmannLa Roche Ltd, Microsynth AG
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL POLYMERASE CHAIN REACTION MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. PCR Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Standard PCR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. RT PCR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Digital PCR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. PCR Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. PCR Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POLYMERASE CHAIN REACTION MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Pharmaceutical & Biotechnology Industries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinical Diagnostics Labs & Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Academic & Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POLYMERASE CHAIN REACTION MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL POLYMERASE CHAIN REACTION INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Bio-Rad Laboratories Inc
    • 8.2.2 Stilla
    • 8.2.3 Standard BioTools
    • 8.2.4 Siemens Healthineers
    • 8.2.5 BioMerieux S.A
    • 8.2.6 Danaher Corporation
    • 8.2.7 Thermo Fisher Scientific Inc
    • 8.2.8 Qiagen N.V
    • 8.2.9 Becton Dickinson & Company (BD)
    • 8.2.10 Abbott Laboratories
    • 8.2.11 Agilent Technologies
    • 8.2.12 F. Hoffmann-La Roche Ltd
    • 8.2.13 Microsynth AG